Literature DB >> 19889065

The relevance of a hypoxic tumour microenvironment in prostate cancer.

Grant D Stewart1, James A Ross, Duncan B McLaren, Christopher C Parker, Fouad K Habib, Antony C P Riddick.   

Abstract

Research into the hypoxic tumour microenvironment is accelerating and the reversal of hypoxia is increasingly being suggested as a mechanism for improving cancer treatment. Recent studies have suggested that hypoxia is also a feature in prostate cancer and is associated with a poor prognosis. Hypoxia has been shown to cause radio-resistance and hence hamper one of the major treatments for prostate cancer. However, unlike other solid tumours, such as cervical and head-and-neck cancer, there are inconsistencies and unanswered questions about the relevance of hypoxia in prostate cancer. This review outlines the role of low-oxygen conditions in prostate cancer and the areas where further studies are required.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889065     DOI: 10.1111/j.1464-410X.2009.08921.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  46 in total

1.  Combining radiation therapy and androgen deprivation for localized prostate cancer-a critical review.

Authors:  A Dal Pra; F L Cury; L Souhami
Journal:  Curr Oncol       Date:  2010-10       Impact factor: 3.677

2.  Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques.

Authors:  Rita Garcia-Parra; David Wood; Rajal B Shah; Javed Siddiqui; Hero Hussain; Hyunjin Park; Timothy Desmond; Charles Meyer; Morand Piert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-16       Impact factor: 9.236

Review 3.  Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment.

Authors:  Gagan Deep; Gati K Panigrahi
Journal:  Crit Rev Oncog       Date:  2015

4.  Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.

Authors:  Kumar Nikhil; Lei Chang; Keith Viccaro; Max Jacobsen; Callista McGuire; Shakti R Satapathy; Michael Tandiary; Meaghan M Broman; Gregory Cresswell; Yizhou J He; George E Sandusky; Timothy L Ratliff; Dipanjan Chowdhury; Kavita Shah
Journal:  Cancer Lett       Date:  2019-02-01       Impact factor: 8.679

5.  Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database.

Authors:  Roberto L Muller; Joseph C Presti; William J Aronson; Martha K Terris; Christopher J Kane; Christopher L Amling; Stephen J Freedland
Journal:  Urology       Date:  2012-03-23       Impact factor: 2.649

6.  Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.

Authors:  Kathrine Røe; Lars Tg Mikalsen; Albert J van der Kogel; Johan Bussink; Heidi Lyng; Anne H Ree; Laure Marignol; Dag R Olsen
Journal:  Radiat Oncol       Date:  2012-05-23       Impact factor: 3.481

7.  Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.

Authors:  Elena V Fernandez; Kelie M Reece; Ariel M Ley; Sarah M Troutman; Tristan M Sissung; Douglas K Price; Cindy H Chau; William D Figg
Journal:  Mol Pharmacol       Date:  2015-03-31       Impact factor: 4.436

Review 8.  What can molecular pathology contribute to the management of renal cell carcinoma?

Authors:  Grant D Stewart; Fiach C O'Mahony; Thomas Powles; Antony C P Riddick; David J Harrison; Dana Faratian
Journal:  Nat Rev Urol       Date:  2011-04-12       Impact factor: 14.432

9.  Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.

Authors:  Jason Boyang Wu; Chen Shao; Xiangyan Li; Qinlong Li; Peizhen Hu; Changhong Shi; Yang Li; Yi-Ting Chen; Fei Yin; Chun-Peng Liao; Bangyan L Stiles; Haiyen E Zhau; Jean C Shih; Leland W K Chung
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

10.  Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.

Authors:  Johanna Tuomela; Tove J Grönroos; Maija P Valta; Jouko Sandholm; Aleksi Schrey; Jani Seppänen; Päivi Marjamäki; Sarita Forsback; Ilpo Kinnunen; Olof Solin; Heikki Minn; Pirkko L Härkönen
Journal:  BMC Cancer       Date:  2010-10-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.